Shire Ord Shs

JE00B2QKY057-GBX

(SWI)

p
Opdateret 03:31:07
ISIN: JE00B2QKY057

Ændring %	0,00%
Ændring	0,00
Volume	0
Høj	P
Lav	P
Åben	P

Seneste luk	P
# af aktier	-
Markedsværdi	-

Idag

Market closed

Marked er lukket, åbner klokken 09:00


Kursudvikling	Seneste	1 uge	1 måned	3 mdr	6 mdr	1 år

		0,0%	0,0%	0,0%	0,0%	0,0%

Dansk
Engelsk
Fondsbørsmeddelelser

	09 maj	Shire Prevails in Litigation over LIALDA Colitis Treatment

	02 maj	EUROPE MARKETS: European Stocks Edge Up As ECB Cuts Rates

	02 maj	LONDON MARKETS: U.K. Stocks End Higher After ECB Rate Cut

	02 maj	EUROPE MARKETS: European Stocks Edge Up As ECB Cuts Rates

	02 maj	LONDON MARKETS: U.K. Stocks Struggle For Direction After ECB Cut

	02 maj	EUROPE MARKETS: European Stocks See Little Benefit From ECB Moves

	02 maj	EUROPE MARKETS: Europe Stocks Slip As ECB Moves Fall Short

	02 maj	LONDON MARKETS: U.K. Stocks Lose Ground After ECB Cut

	02 maj	LONDON MARKETS: U.K. Stocks Bounce Steady After ECB Cut

	02 maj	Shire 1Q US GAAP Operating. Income -56%, Backs Fiscal Year View; Unveils New Structure

Flere nyheder

Konsensusmål

2315,38 GBP

P/E (2013E)

14,9x

K/I (2013E)

3,78x

Direkte afkast (2013E)

0,6%

Konsensus anbefaling

Sælg

Hold

Køb

Åbn analyse

Kilde: FactSet Research

Shire is a specialty biopharmaceutical company with sales focusing on ADHD drugs and orphan drugs relating to genetic disorders. Because of this latter focus the company can earn high protected margins from the competition barriers in the orphan drug sector, which also partially shields the company from patent challenges thereby reducing their operational risk.

Shire Ord Shs

For lav Flash Player version

Nyheder om Shire Ord Shs

Dagens Aktie - Shire Ord Shs

Firma profil